openPR Logo
Press release

Investigation announced for Long-Term Investors in shares of GoodRx Holdings, Inc. (NASDAQ: GDRX)

03-19-2021 02:25 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in GoodRx Holdings, Inc. (NASDAQ: GDRX) shares.

An investigation on behalf of current long term investors in GoodRx Holdings, Inc. (NASDAQ: GDRX) shares.

An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of GoodRx Holdings, Inc.

Investors who are current long term investors in GoodRx Holdings, Inc. (NASDAQ: GDRX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: GDRX stocks follows a lawsuit filed against GoodRx Holdings, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: GDRX stocks, concerns whether certain GoodRx Holdings, Inc. officers and directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Central District of California the plaintiff alleges that, at the time of the IPO, unbeknownst to investors, Amazon.com, Inc. (“Amazon”) was developing and would soon introduce its own online and mobile prescription medication ordering and fulfillment service that would directly compete with GoodRx. Defendants timed the IPO so that it was priced before Amazon announced its online pharmaceutical business to facilitate the IPO and create artificial demand for the common shares sold therein, as well to maximize the amount of money the Company and the selling stockholders could raise in the IPO. Given defendants’ knowledge of Amazon’s intention to enter the online pharmaceutical business, their statements in the Registration Statement and during the Class Period about GoodRx’s competitive position were materially false and/or misleading when made and caused GoodRx Class A common stock to trade at artificially inflated prices of more than $64 per share between September 23, 2020 and November 16, 2020.

Those who purchased shares of GoodRx Holdings, Inc. (NASDAQ: GDRX) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in shares of GoodRx Holdings, Inc. (NASDAQ: GDRX) here

News-ID: 2258873 • Views: 665

More Releases from Shareholders Foundation

Lawsuit filed for Investors in shares of CytoDyn Inc. (OTC: CYDY)
An investor, who purchased shares of CytoDyn Inc. (OTC: CYDY), filed a lawsuit over alleged violations of Federal Securities Laws by CytoDyn Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of CytoDyn Inc. (OTC: CYDY) have certain options and for certain investors are short and strict deadlines running. Deadline: May 17, 2021. OTC: CYDY investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Investigation announced for Long-Term Investors in shares of SolarWinds Corporat …
An investigation on was announced concerning potential breaches of fiduciary duties by certain directors and officers of SolarWinds Corporation. Investors who are current long term investors in SolarWinds Corporation (NYSE: SWI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: SWI stocks follows a lawsuit filed against SolarWinds Corporation
Update in Lawsuit for Investors in shares of Merit Medical Systems, Inc. (NYSE: …
An investor in Merit Medical Systems, Inc. (NYSE: MMSI) shares filed a lawsuit in December 2019, against Merit Medical Systems, Inc. over alleged violations of Federal Securities Laws. Investors who purchased shares of Merit Medical Systems, Inc. (NYSE: MMSI) prior to February 2019 and continue to hold any of those shares, have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. After the market
Deadline on May 3rd coming up in Lawsuit for Investors in Velodyne Lidar, Inc. ( …
A deadline is coming up on May 3, 2021 in the lawsuit filed for certain investors of Velodyne Lidar, Inc. (NASDAQ: VLDR) over alleged securities laws violations by Velodyne Lidar, Inc. Investors who purchased shares of Velodyne Lidar, Inc. (NASDAQ: VLDR) have certain options and there are strict and short deadlines running. Deadline: May 3, 2021. NASDAQ: VLDR stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for GoodRx

Deadline on Feb. 16th coming up in Lawsuit for Investors in GoodRx Holdings, Inc …
A deadline is coming up on February 16, 2020 in the lawsuit filed for certain investors of GoodRx Holdings, Inc. (NASDAQ: GDRX). Investors who purchased shares of GoodRx Holdings, Inc. (NASDAQ: GDRX) have certain options and there are strict and short deadlines running. Deadline: February 16, 2020. NASDAQ: GDRX stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the complaint filed in the U.S. District
Lawsuit filed for Investors in shares of GoodRx Holdings, Inc. (NASDAQ: GDRX) I
An investor, who purchased shares of GoodRx Holdings, Inc. (NASDAQ: GDRX), filed a lawsuit over alleged Securities Laws violations by GoodRx Holdings, Inc. Investors who purchased shares of GoodRx Holdings, Inc. (NASDAQ: GDRX) have certain options and for certain investors are short and strict deadlines running. Deadline: February 16, 2020. NASDAQ: GDRX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On August 28, 2020, GoodRx Holdings,
Mobile Health Apps and Solutions Market Overview 2020 | Runtastic, Nike, MyFitne …
According to COHERENT MARKET INSIGHTS Research's latest research report, the global Mobile Health Apps and Solutions market is estimated to be valued at XX Million US$ in 2019 and is projected to reach XX Million US$ by 2027, expanding at a CAGR of XX% during the forecast period. The report on Mobile Health Apps and Solutions market provides qualitative as well as quantitative analysis in terms of market dynamics, competition
Mobile Health Apps and Solutions Market Growth Recommendations By Experts Nike, …
Proliferation of mobile devices provides an entirely new and effective dimension to the healthcare industry, wherein solutions can be provided to end users in an extremely easy-to-use manner that can be accessed irrespective of the use location. Advent of mHealth apps and solutions have led the healthcare solutions market to expand its reach from hospitals to primary care and office space. The industry is witnessing influx of various start-ups
Mobile Health Apps and Solutions Market - Emergence of Connected and Integrated …
Mobile Health Apps and Solutions Market Overview Proliferation of mobile devices provides an entirely new and effective dimension to the healthcare industry, wherein solutions can be provided to end users in an extremely easy-to-use manner that can be accessed irrespective of the use location. Advent of mHealth apps and solutions have led the healthcare solutions market to expand its reach from hospitals to primary care and office space. The industry
MOBILE HEALTH APPS AND SOLUTIONS MARKET UPDATES TILL 2026 EXPLORE BY PROMINENT P …
Proliferation of mobile devices provides an entirely new and effective dimension to the healthcare industry, wherein solutions can be provided to end users in an extremely easy-to-use manner that can be accessed irrespective of the use location. Advent of mHealth apps and solutions have led the healthcare solutions market to expand its reach from hospitals to primary care and office space. The industry is witnessing influx of various start-ups